Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 11/20 | 0.93 |
| ▸ | LPAR2 | Q9HBW0 | 10/20 | 0.93 |
| ▸ | LPAR1 | Q92633 | 8/20 | 0.93 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.64 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.54 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.54 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.54 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.54 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | TSPO | P30536 | 1/20 | 0.54 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.54 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18123889 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL4981337 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL193118 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL19821294 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL7781151 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL23016698 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL4981351 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL38660089 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL193119 | 1.00 | LPAR3 (0.93) | LPAR3LPAR2LPAR1ENPP2S1PR4 | |
| SCHEMBL11757308 | 0.98 | LPAR3 (0.90) | LPAR3LPAR2LPAR1ENPP2S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1634 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132328-A1 | TREATMENT COMPOSITIONS INCLUDING ASPHALTENIC OIL | CHAMPIONX LLC (US) | 2026-05-14 | — | — | US | claimed |
| EP-3995550-B1 | POLISHING COMPOSITIONS AND METHODS OF USING SAME | FUJIFILM ELECTRONIC MAT USA INC (US) | 2026-04-01 | — | — | EP | claimed |
| EP-3947522-B1 | PROCESS FOR PROVIDING A HOMOGENEOUS POLYETHER POLYOL COMPOSITION, REACTION MIXTURE COMPRISING A COMPOSITION OBTAINED BY THE PROCESS, AND POLYURETHANE PRODUCTS OBTAINED FROM THE REACTION MIXTURE | HUNTSMAN INT LLC (US) | 2025-10-15 | — | — | EP | claimed |
| WO-2025110241-A1 | METHOD FOR PRODUCING 1,1,2-TRISUBSTITUTED ETHANE AND METHOD FOR PRODUCING 1,1-DISUBSTITUTED OLEFIN | 東亞合成株式会社 | 2025-05-30 | — | — | WO | claimed |
| CN-116731774-B | Rolling fluid composition and application thereof | 季华实验室 | 2025-05-27 | — | — | CN | claimed |
| US-20250143359-A1 | COMPOUNDS THAT MODULATE GPR92 RECEPTOR ACTIVITY AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS, INCORPORATED (US) | 2025-05-08 | — | — | US | claimed |
| WO-2025072075-A1 | METHOD OF PRODUCING FLUOROPOLYMERS USING PHOSPHATE ESTER | ARKEMA INC. (US) | 2025-04-03 | — | — | WO | claimed |
| CN-119684502-A | Multifunctional adhesive, preparation method and application thereof | 华中科技大学 | 2025-03-25 | — | — | CN | claimed |
| CN-119505981-A | Water-soluble heavy-duty forming oil and preparation method thereof | 季华实验室 | 2025-02-25 | — | — | CN | claimed |
| US-20250049771-A1 | METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS | ARCUTIS BIOTHERAPEUTICS, INC. (US) | 2025-02-13 | — | — | US | claimed |
| EP-0135932-B1 | LUBRICANT FOR METAL FORMING AND PROCESS FOR METAL FORMING | HITACHI, LTD. (JP) | 1990-05-02 | — | — | EP | claimed |
| US-4900459-A | Metal processing lubricating oil composition and process for producing the same | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 1990-02-13 | — | — | US | claimed |
| US-4629748-A | INCLUDING AN ALKYL PHOSPHATE, AN AMINE OR ETHYLENE GLYCOL-PROPYLENE GLYCOL BLOCK POLYMER; ANTIFOULING AGENTS | PILOT MAN-NEN-HITSU KABUSHIKI KAISHA (JP) | 1986-12-16 | — | — | US | claimed |
| US-4612127-A | INORGANIC CONDENSED PHOSPHORUS COMPOUND | HITACHI, LTD. (JP) | 1986-09-16 | — | — | US | claimed |
| EP-0146140-A2 | Process for metal forming | HITACHI, LTD. (JP) | 1985-06-26 | — | — | EP | claimed |
| EP-0135932-A2 | Lubricant for metal forming and process for metal forming | HITACHI, LTD. (JP) | 1985-04-03 | — | — | EP | claimed |
| US-4501795-A | PARTICLES COATED WITH REACTION PRODUCT OF AN ISOCYANATE AND A PHOSPHORIC ESTER | KAO CORPORATION (JP) | 1985-02-26 | — | — | US | claimed |
| US-4460692-A | COMBSTTING OIL POLLUTION OF SEAS BY BIOLOGICAL DEGRADATION | SOCIETE NATIONALE ELF AQUITAINE (PRODUCTION) (FR) | 1984-07-17 | — | — | US | claimed |
| US-4184978-A | Stable water in oil emulsion systems for cosmetic and pharmaceutical preparations | C. J. PATTERSON COMPANY (US) | 1980-01-22 | — | — | US | claimed |
| US-4129507-A | NONFUMING, STABLE FINISH FOR TIRE CORD YARN, OXIDIZED POLYETHYLENEWAX | ALLIED CHEMICAL CORPORATION (US) | 1978-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049771-A1 | METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS | PDE12, PDE4A, SMPD4 | LPAR3 1226/4885LPAR2 1438/4885LPAR1 1148/4885 |
| US-20260132328-A1 | TREATMENT COMPOSITIONS INCLUDING ASPHALTENIC OIL | ORAI1, SHH, CA2 | LPAR3 3624/4885LPAR2 1940/4885LPAR1 2368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.